MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L
MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was si...
Gespeichert in:
Veröffentlicht in: | Experimental and therapeutic medicine 2020-09, Vol.20 (3), p.2252-2261 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2261 |
---|---|
container_issue | 3 |
container_start_page | 2252 |
container_title | Experimental and therapeutic medicine |
container_volume | 20 |
creator | Pan, Yuejiang Jin, Ke Xie, Xuan Wang, Kexi Zhang, Huizhong |
description | MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment. |
doi_str_mv | 10.3892/etm.2020.8926 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7401917</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A635435151</galeid><sourcerecordid>A635435151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-762dacce925758e55601fbf227f78924db9ebf95e5f4fa7a929429a5049657d83</originalsourceid><addsrcrecordid>eNptUsuOFCEUrRiNMxln6Z7EjZtugSqKYmPSTnwl7SPGWROKunQzoaCFqjGzMPEX_EW_xFtORzNGSIDLPeeQE05VPWZ0XXeKP4NpXHPK6RqL9l51yqTiK0aZuH88U9Wxk-q8lCuKQ7Ss68TD6qTmshWS8tPq2ztvc_r0fvPz-w-mDK71gfi4972fCpn2QCyEMAeTySGn4B1kM_kUiYkD4q5NWYrkSEwRyWU0IfymkDDHHbEmWsikvyFD-hoz7FBp8ti4fLH5yLePqgfOhALnx_2sunz18vPFm9X2w-u3F5vtyqLNaSVbPhhrQXEhRQdCtJS53nEunUTnzdAr6J0SIFzjjDSKq4YrI2ij0ObQ1WfV81vdw9yPMFiIUzZBH7IfTb7RyXh9txP9Xu_StZYNZYpJFHh6FMjpywxl0qMvi00TIc1F86ZmHad10yD0yT_QqzTniPYWlKgFo4L_Re1MAO2jS_iuXUT1pq0FAplgiFr_B4VzgNHbFMF5vL9DWN0S8FNLyeD-eGRUL5HRGBm9REYvkal_AX2itKE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435351052</pqid></control><display><type>article</type><title>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</title><source>PubMed Central</source><creator>Pan, Yuejiang ; Jin, Ke ; Xie, Xuan ; Wang, Kexi ; Zhang, Huizhong</creator><creatorcontrib>Pan, Yuejiang ; Jin, Ke ; Xie, Xuan ; Wang, Kexi ; Zhang, Huizhong</creatorcontrib><description>MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2020.8926</identifier><identifier>PMID: 32765702</identifier><language>eng</language><publisher>Athens: Spandidos Publications</publisher><subject>Apoptosis ; Breast cancer ; Cancer metastasis ; Cancer therapies ; Cell adhesion & migration ; Cell growth ; Chemotherapy ; Comparative analysis ; Development and progression ; Gene expression ; Kinases ; Liver cancer ; Lung cancer ; Lymphoma ; MicroRNA ; MicroRNAs ; Non-small cell lung cancer ; Phase transitions ; Prostate cancer ; Radiation therapy ; Small cell lung cancer ; Surgery ; Wound healing</subject><ispartof>Experimental and therapeutic medicine, 2020-09, Vol.20 (3), p.2252-2261</ispartof><rights>COPYRIGHT 2020 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2020</rights><rights>Copyright © 2020, Spandidos Publications 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-762dacce925758e55601fbf227f78924db9ebf95e5f4fa7a929429a5049657d83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401917/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401917/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Pan, Yuejiang</creatorcontrib><creatorcontrib>Jin, Ke</creatorcontrib><creatorcontrib>Xie, Xuan</creatorcontrib><creatorcontrib>Wang, Kexi</creatorcontrib><creatorcontrib>Zhang, Huizhong</creatorcontrib><title>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</title><title>Experimental and therapeutic medicine</title><description>MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.</description><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Cancer metastasis</subject><subject>Cancer therapies</subject><subject>Cell adhesion & migration</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Comparative analysis</subject><subject>Development and progression</subject><subject>Gene expression</subject><subject>Kinases</subject><subject>Liver cancer</subject><subject>Lung cancer</subject><subject>Lymphoma</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>Non-small cell lung cancer</subject><subject>Phase transitions</subject><subject>Prostate cancer</subject><subject>Radiation therapy</subject><subject>Small cell lung cancer</subject><subject>Surgery</subject><subject>Wound healing</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptUsuOFCEUrRiNMxln6Z7EjZtugSqKYmPSTnwl7SPGWROKunQzoaCFqjGzMPEX_EW_xFtORzNGSIDLPeeQE05VPWZ0XXeKP4NpXHPK6RqL9l51yqTiK0aZuH88U9Wxk-q8lCuKQ7Ss68TD6qTmshWS8tPq2ztvc_r0fvPz-w-mDK71gfi4972fCpn2QCyEMAeTySGn4B1kM_kUiYkD4q5NWYrkSEwRyWU0IfymkDDHHbEmWsikvyFD-hoz7FBp8ti4fLH5yLePqgfOhALnx_2sunz18vPFm9X2w-u3F5vtyqLNaSVbPhhrQXEhRQdCtJS53nEunUTnzdAr6J0SIFzjjDSKq4YrI2ij0ObQ1WfV81vdw9yPMFiIUzZBH7IfTb7RyXh9txP9Xu_StZYNZYpJFHh6FMjpywxl0qMvi00TIc1F86ZmHad10yD0yT_QqzTniPYWlKgFo4L_Re1MAO2jS_iuXUT1pq0FAplgiFr_B4VzgNHbFMF5vL9DWN0S8FNLyeD-eGRUL5HRGBm9REYvkal_AX2itKE</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Pan, Yuejiang</creator><creator>Jin, Ke</creator><creator>Xie, Xuan</creator><creator>Wang, Kexi</creator><creator>Zhang, Huizhong</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200901</creationdate><title>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</title><author>Pan, Yuejiang ; Jin, Ke ; Xie, Xuan ; Wang, Kexi ; Zhang, Huizhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-762dacce925758e55601fbf227f78924db9ebf95e5f4fa7a929429a5049657d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Cancer metastasis</topic><topic>Cancer therapies</topic><topic>Cell adhesion & migration</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Comparative analysis</topic><topic>Development and progression</topic><topic>Gene expression</topic><topic>Kinases</topic><topic>Liver cancer</topic><topic>Lung cancer</topic><topic>Lymphoma</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>Non-small cell lung cancer</topic><topic>Phase transitions</topic><topic>Prostate cancer</topic><topic>Radiation therapy</topic><topic>Small cell lung cancer</topic><topic>Surgery</topic><topic>Wound healing</topic><toplevel>online_resources</toplevel><creatorcontrib>Pan, Yuejiang</creatorcontrib><creatorcontrib>Jin, Ke</creatorcontrib><creatorcontrib>Xie, Xuan</creatorcontrib><creatorcontrib>Wang, Kexi</creatorcontrib><creatorcontrib>Zhang, Huizhong</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Yuejiang</au><au>Jin, Ke</au><au>Xie, Xuan</au><au>Wang, Kexi</au><au>Zhang, Huizhong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L</atitle><jtitle>Experimental and therapeutic medicine</jtitle><date>2020-09-01</date><risdate>2020</risdate><volume>20</volume><issue>3</issue><spage>2252</spage><epage>2261</epage><pages>2252-2261</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>MicroRNAs (miRNAs) are increasingly recognized as important regulators of non-small cell lung cancer (NSCLC) progression by directly regulating their target genes. The aim of the present study was to assess the biological role of miR-19a-3p in NSCLC. It was revealed that miR-19a-3p expression was significantly downregulated in human NSCLC tissues and cell lines compared with normal tissues and lung epithelial cells. In addition, a lower miR-19a-3p expression was significantly associated with Tumor Node Metastasis stage and lymph node metastasis. Furthermore, the upregulation of miR-19a-3p in NSCLC cell lines significantly inhibited cell proliferation, migration and invasion, as determined using an MTT, colony formation, wound healing and transwell Matrigel invasion assays, respectively. A luciferase reporter assay and western blotting determined that ubiquitin associated protein 2 like (UBAP2L) was a direct target of miR-19a-3p and could be inhibited through the upregulation of miR-19a-3p in NSCLC. In addition, UBAP2L silencing induced similar effects to those observed following miR-19a-3p overexpression. The overexpression of UBAP2L partially reversed the effects of miR-19a-3p on NSCLC cell lines. Collectively, these data indicated that miR-19a-3p may serve as a tumor suppressor partly through the regulation of UBAP2L expression in NSCLC and that the targeting of miR-19a-3p may be a novel method for NSCLC treatment.</abstract><cop>Athens</cop><pub>Spandidos Publications</pub><pmid>32765702</pmid><doi>10.3892/etm.2020.8926</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1792-0981 |
ispartof | Experimental and therapeutic medicine, 2020-09, Vol.20 (3), p.2252-2261 |
issn | 1792-0981 1792-1015 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7401917 |
source | PubMed Central |
subjects | Apoptosis Breast cancer Cancer metastasis Cancer therapies Cell adhesion & migration Cell growth Chemotherapy Comparative analysis Development and progression Gene expression Kinases Liver cancer Lung cancer Lymphoma MicroRNA MicroRNAs Non-small cell lung cancer Phase transitions Prostate cancer Radiation therapy Small cell lung cancer Surgery Wound healing |
title | MicroRNA‑19a‑3p inhibits the cellular proliferation and invasion of non‑small cell lung cancer by downregulating UBAP2L |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T05%3A37%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA%E2%80%9119a%E2%80%913p%20inhibits%20the%20cellular%20proliferation%20and%20invasion%20of%20non%E2%80%91small%20cell%20lung%20cancer%20by%20downregulating%20UBAP2L&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Pan,%20Yuejiang&rft.date=2020-09-01&rft.volume=20&rft.issue=3&rft.spage=2252&rft.epage=2261&rft.pages=2252-2261&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2020.8926&rft_dat=%3Cgale_pubme%3EA635435151%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2435351052&rft_id=info:pmid/32765702&rft_galeid=A635435151&rfr_iscdi=true |